Screening for High Lipoprotein(a)
- PMID: 30883219
- PMCID: PMC6880754
- DOI: 10.1161/CIRCULATIONAHA.119.038989
Screening for High Lipoprotein(a)
Keywords: Editorials; lipoproteins.
Comment on
-
Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.Circulation. 2019 Mar 19;139(12):1483-1492. doi: 10.1161/CIRCULATIONAHA.118.037184. Circulation. 2019. PMID: 30586750 Clinical Trial.
-
Lipoprotein(a) Levels and the Risk of Myocardial Infarction Among 7 Ethnic Groups.Circulation. 2019 Mar 19;139(12):1472-1482. doi: 10.1161/CIRCULATIONAHA.118.034311. Circulation. 2019. PMID: 30667276
Similar articles
-
From lipoprotein apheresis to proprotein convertase subtilisin/kexin type 9 inhibitors: Impact on low-density lipoprotein cholesterol and C-reactive protein levels in cardiovascular disease patients.Eur J Prev Cardiol. 2018 Nov;25(17):1843-1851. doi: 10.1177/2047487318792626. Epub 2018 Jul 30. Eur J Prev Cardiol. 2018. PMID: 30058841
-
Update on proprotein convertase subtilisin/kexin type 9 inhibitors, lipoprotein(a) and cardiovascular risk.Curr Opin Lipidol. 2021 Oct 1;32(5):324-327. doi: 10.1097/MOL.0000000000000771. Curr Opin Lipidol. 2021. PMID: 34472540 No abstract available.
-
Circulating Complex of Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 in the Serum Measured by ELISA.Bull Exp Biol Med. 2020 Sep;169(5):639-643. doi: 10.1007/s10517-020-04944-0. Epub 2020 Sep 26. Bull Exp Biol Med. 2020. PMID: 32979126
-
[Clinical significance of and treatment options for increased lipoprotein(a)].Orv Hetil. 2014 Apr 20;155(16):607-14. doi: 10.1556/OH.2014.29877. Orv Hetil. 2014. PMID: 24733102 Review. Hungarian.
-
Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables.J Cardiovasc Pharmacol Ther. 2018 Jan;23(1):3-12. doi: 10.1177/1074248417724868. Epub 2017 Aug 22. J Cardiovasc Pharmacol Ther. 2018. PMID: 28826253 Review.
Cited by
-
Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing.Front Cardiovasc Med. 2025 Feb 10;12:1545787. doi: 10.3389/fcvm.2025.1545787. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 39995970 Free PMC article.
-
Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).Atherosclerosis. 2022 Dec;363:102-108. doi: 10.1016/j.atherosclerosis.2022.10.004. Epub 2022 Oct 8. Atherosclerosis. 2022. PMID: 36253168 Free PMC article.
-
Elevated Lp(a) and course of COVID-19: Is there a relationship?PLoS One. 2022 Jun 8;17(6):e0266814. doi: 10.1371/journal.pone.0266814. eCollection 2022. PLoS One. 2022. PMID: 35675355 Free PMC article.
-
Lipoprotein(a) and Major Adverse Cardiovascular Events in Patients With or Without Baseline Atherosclerotic Cardiovascular Disease.J Am Coll Cardiol. 2024 Mar 5;83(9):873-886. doi: 10.1016/j.jacc.2023.12.031. J Am Coll Cardiol. 2024. PMID: 38418000 Free PMC article.
-
Living with Elevated Lipoprotein(a) Levels: The Experiences of Patients and Caregivers.Patient Prefer Adherence. 2025 Feb 21;19:395-405. doi: 10.2147/PPA.S478623. eCollection 2025. Patient Prefer Adherence. 2025. PMID: 40008374 Free PMC article.
References
-
- Scandinavian Simvastatin Survival Study G. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet. 1994;344:1383–1389. - PubMed
-
- Afshar M and Thanassoulis G. Lipoprotein(a): new insights from modern genomics. Current opinion in lipidology. 2017;28:170–176. - PubMed
-
- Thanassoulis G, Campbell CY, Owens DS, Smith JG, Smith AV, Peloso GM, Kerr KF, Pechlivanis S, Budoff MJ, Harris TB, Malhotra R, O’Brien KD, Kamstrup PR, Nordestgaard BG, Tybjaerg-Hansen A, Allison MA, Aspelund T, Criqui MH, Heckbert SR, Hwang SJ, Liu Y, Sjogren M, van der Pals J, Kalsch H, Muhleisen TW, Nothen MM, Cupples LA, Caslake M, Di Angelantonio E, Danesh J, Rotter JI, Sigurdsson S, Wong Q, Erbel R, Kathiresan S, Melander O, Gudnason V, O’Donnell CJ and Post WS. Genetic associations with valvular calcification and aortic stenosis. The New England journal of medicine. 2013;368:503–12. - PMC - PubMed
-
- Kamstrup PR, Tybjaerg-Hansen A, Steffensen R and Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. Jama. 2009;301:2331–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous